OncoMed Pharmaceuticals Inc Assets, Fair Value Disclosure
OncoMed Pharmaceuticals Inc had Assets, Fair Value Disclosure of $147.62 million as of 2016-12-31, per its 10-K filed 2017-03-09.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:AssetsFairValueDisclosure · last filed 2017-03-09
- 2016-12-31: Assets, Fair Value Disclosure $147.62M.
- 2016-09-30: Assets, Fair Value Disclosure $177.79M.
- 2016-06-30: Assets, Fair Value Disclosure $134.18M.
- 2016-03-31: Assets, Fair Value Disclosure $108.97M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2016-12-31 | $147.62M 10-K · filed 2017-03-09 |
| 2016-09-30 | $177.79M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $134.18M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $108.97M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $118.83M 10-K · filed 2017-03-09 |
| 2015-09-30 | $144.94M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $172.46M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $192.40M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $212.29M 10-K · filed 2016-03-10 |
| 2014-09-30 | $226.32M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $251.25M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $266.23M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $275.24M 10-K · filed 2015-03-12 |
| 2013-09-30 | $125.23M 10-Q · filed 2013-11-13 |
| 2013-06-30 | $47.94M 10-Q · filed 2013-09-03 |
| 2012-12-31 | $57.91M 10-K · filed 2014-03-18 |